MYC and diffuse large B-cell lymphoma: Furthermore, treatment options for relapsed DLBCL in the CNS are limited and patients with an MYC translocation tend to have a poor response to salvage chemotherapy.25, 26 Salvage therapy for a relapse after stage I(E) disease is not trivial and emphasizes the necessity to improve first line treatment in these patients as well.